Gago Sara, Esteban Cristina, Valero Clara, Zaragoza Oscar, Puig de la Bellacasa Jorge, Buitrago María José
Mycology Department, National Centre for Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
J Clin Microbiol. 2014 Apr;52(4):1168-76. doi: 10.1128/JCM.02895-13. Epub 2014 Jan 29.
A molecular diagnostic technique based on real-time PCR was developed for the simultaneous detection of three of the most frequent causative agents of fungal opportunistic pneumonia in AIDS patients: Pneumocystis jirovecii, Histoplasma capsulatum, and Cryptococcus neoformans/Cryptococcus gattii. This technique was tested in cultured strains and in clinical samples from HIV-positive patients. The methodology used involved species-specific molecular beacon probes targeted to the internal transcribed spacer regions of the rDNA. An internal control was also included in each assay. The multiplex real-time PCR assay was tested in 24 clinical strains and 43 clinical samples from AIDS patients with proven fungal infection. The technique developed showed high reproducibility (r(2) of >0.98) and specificity (100%). For H. capsulatum and Cryptococcus spp., the detection limits of the method were 20 and 2 fg of genomic DNA/20 μl reaction mixture, respectively, while for P. jirovecii the detection limit was 2.92 log10 copies/20 μl reaction mixture. The sensitivity in vitro was 100% for clinical strains and 90.7% for clinical samples. The assay was positive for 92.5% of the patients. For one of the patients with proven histoplasmosis, P. jirovecii was also detected in a bronchoalveolar lavage sample. No PCR inhibition was detected. This multiplex real-time PCR technique is fast, sensitive, and specific and may have clinical applications.
开发了一种基于实时PCR的分子诊断技术,用于同时检测艾滋病患者中三种最常见的真菌性机会性肺炎病原体:耶氏肺孢子菌、荚膜组织胞浆菌和新生隐球菌/格特隐球菌。该技术在培养菌株和HIV阳性患者的临床样本中进行了测试。所使用的方法涉及针对rDNA内部转录间隔区的物种特异性分子信标探针。每次检测还包括一个内部对照。多重实时PCR检测在24株临床菌株和43份来自确诊真菌感染的艾滋病患者的临床样本中进行。所开发的技术显示出高重现性(r(2)>0.98)和特异性(100%)。对于荚膜组织胞浆菌和隐球菌属,该方法的检测限分别为20和2 fg基因组DNA/20 μl反应混合物,而对于耶氏肺孢子菌,检测限为2.92 log10拷贝/20 μl反应混合物。体外对临床菌株的敏感性为100%,对临床样本的敏感性为90.7%。该检测对92.5%的患者呈阳性。对于一名确诊组织胞浆菌病的患者,在支气管肺泡灌洗样本中也检测到了耶氏肺孢子菌。未检测到PCR抑制。这种多重实时PCR技术快速、灵敏且特异,可能具有临床应用价值。